Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001120478-26-000013
Filing Date
2026-04-24
Accepted
2026-04-24 16:19:14
Documents
1
Period of Report
2026-04-23

Document Format Files

Seq Description Document Type Size
1 form4-04242026_080410.html 4  
1 form4-04242026_080410.xml 4 5715
  Complete submission text file 0001120478-26-000013.txt   7199
Mailing Address C/O BIOAGE LABS, INC. 5885 HOLLIS STREET, SUITE 370 EMERYVILLE CA 94608
Business Address
GOLDSTEIN DOV A MD (Reporting) CIK: 0001120478 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-42279 | Film No.: 26894346

Mailing Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608
Business Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608 510-806-1445
BioAge Labs, Inc. (Issuer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)